NASDAQ:INO

Inovio Pharmaceuticals Earning Date

USA |NASDAQ |USD

INO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.33 $-0.39 $0.11
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $970.00K $272.82K $236.18K

Inovio Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

INO Earnings Date & History Chart

INO Earnings & Revenue Forecast

INO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-0.31 $-0.45 $-0.05
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-1.30 $-1.54 $-1.06
Dec 2022 10 $-0.73 $-2.73 $1.63

INO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.31 $-0.22 $-0.19
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.30 $-1.07 $-0.94
Dec 2022 0 / 0 $-0.73 $-0.65 $-0.55

INO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 9 $12.96M $120.00K $91.25M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $14.53M $800.00K $93.14M
Dec 2022 9 $181.43M $600.00K $843.14M

INO Earnings Date & Revenue History

INO Earnings History

|
Show More
Show More

INO Revenue History

|
Show More
Show More

Inovio Pharmaceuticals Next Earnings Date & Report

INO Next Earnings Date & Report Preview: Sep 2021 (FQ)

INO's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 10 analysts, the average EPS estimation for Inovio Pharmaceuticals's next quarterly earnings is $-0.33, with a low EPS estimation of $-0.42, and a high estimation of $-0.23.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.33, the last 2 month trend is $-0.24, and the 3 month trend is $-0.23.

Based on 9 analysts, the average revenue estimation is $970.00K, with a low revenue estimation of $120.00K, and a high estimation of $3.70M.

Inovio Pharmaceuticals Previous Earnings Dates & Reports

INO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Inovio Pharmaceuticals's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.

INO's earnings per share (EPS) was $-0.39, missing the consensus analysts forecast of $-0.25 by -56.63%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 44.44%, and higher than the same period a year before (Jun 2020) by -53.01%.

Revenues were $272.82K, worse than the forecast of $273.00K by -0.06%, down by -26.49% from the previous quarter , and up by 2.11% from the same period last year.

The company reported a net income of $-82.14M.

Free cash flow for the quarter was $-78.67M , compared to $-53.08M last quarter and $-27.19M a year before.

INO ended the quarter with $33.80M in total debt, a decrease of -0.31% compared to the previous quarter, and a decrease of -85.67% compared to the same quarter a year before.

INO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Inovio Pharmaceuticals's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.

INO's earnings per share (EPS) was $-1.09, beating the consensus analysts forecast of $-1.17 by -6.84% , and higher than the previous year's EPS (Dec 2019) by -9.92%.

Revenues were $7.41M, better than the forecast of $3.07M by 141.41%, and up by 80.24% from previous year's revenue.

The company reported a net income of $-166.41M.

Inovio Pharmaceuticals reported a free cash flow of $-179.50M for its fiscal year, compared to $-98.84M a year ago.

The company ended the fiscal year with $20.99M in total debt, a decrease of -73.47% compared to the previous year.